Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announced today that an abstract was presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place on Oct. 5-8 in […]
Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
BOCA RATON, Fla., Oct. 9, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), announces that at the American Society for Dermatologic Surgery (ASDS) annual meeting, which took place October 5th-8th in Chicago, an abstract was presented illustrating […]
Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference
BOCA RATON, Fla., Sept. 20, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will present at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 26, 2017 at 4:00 p.m. Eastern time. The […]
Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma
BOCA RATON, Fla., Sept. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that management will not be able to present at the Rodman & Renshaw Global Investment Conference due to the impact of […]
Sensus Healthcare to Present at Upcoming Investor Conferences
Management unable to present at Liolios Gateway conference due to Hurricane Irma BOCA RATON, Fla., Sept. 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will […]
Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
BOCA RATON, Fla., Aug. 23, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel […]
Sensus Healthcare Reports Record Second Quarter Financial Results
Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., Aug. 3, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids
BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]
Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017
BOCA RATON, Fla., July 25, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, August 3, 2017 to discuss the financial […]
Sensus to Present at the 2017 Marcum MicroCap Conference
BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on […]
